Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
Open Access
- 29 November 2019
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2760
- https://doi.org/10.3389/fimmu.2019.02760
Abstract
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!This publication has 32 references indexed in Scilit:
- In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administrationJournal of Controlled Release, 2019
- Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?Expert Opinion on Drug Delivery, 2018
- Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambsmAbs, 2018
- Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protectionnpj Vaccines, 2017
- Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricinJournal of Controlled Release, 2016
- Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus InfectionJournal of Virology, 2016
- Direct Administration in the Respiratory Tract Improves Efficacy of Broadly Neutralizing Anti-Influenza Virus Monoclonal AntibodiesAntimicrobial Agents and Chemotherapy, 2015
- Nebulization as a delivery method for mAbs in respiratory diseasesExpert Opinion on Drug Delivery, 2015
- Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)Online Journal of Public Health Informatics, 2006
- Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medicationsBritish Journal of Clinical Pharmacology, 2003